Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antihistamine Allergy”

123 trials

Showing 20 of 123 results

Large-scale testing (Phase 3)Study completedNCT05030311
What this trial is testing

Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 470
Large-scale testing (Phase 3)Study completedNCT05774639
What this trial is testing

Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
Kashiv BioSciences, LLC 600
Large-scale testing (Phase 3)Looking for participantsNCT06868212
What this trial is testing

Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria (CSU)
Novartis Pharmaceuticals 400
Not applicableWithdrawnNCT01661777
What this trial is testing

Refractory Eustachian Tube Dysfunction: Are the Symptoms Related to Endolymphatic Hydrops

Who this might be right for
Eustachian Tube DysfunctionEndolymphatic Hydrops
Vanderbilt University
Testing effectiveness (Phase 2)Looking for participantsNCT07415551
What this trial is testing

Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines

Who this might be right for
Allergic DiseasesChronic Spontaneous Urticaria (CSU)
Yuhan Corporation 150
Early research (Phase 1)Study completedNCT00947063
What this trial is testing

To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions

Who this might be right for
Allergy
Sandoz 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486583
What this trial is testing

Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.

Who this might be right for
Chronic Idiopathic Urticaria
Cairo University 40
Early research (Phase 1)Study completedNCT00837837
What this trial is testing

Study Evaluating Chlorpheniramine Maleate Liquid in Children and Adolescents

Who this might be right for
Allergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT03926611
What this trial is testing

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 311
Large-scale testing (Phase 3)Study completedNCT05032157
What this trial is testing

Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 455
Post-approval studies (Phase 4)Study completedNCT02507635
What this trial is testing

Anti-inflammatory H1 Antihistamines Allergic Rhinitis

Who this might be right for
Allergic Rhinitis
Iuliu Hatieganu University of Medicine and Pharmacy 115
Early research (Phase 1)Study completedNCT00946608
What this trial is testing

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

Who this might be right for
Allergy
Sandoz 30
Testing effectiveness (Phase 2)Study completedNCT03749135
What this trial is testing

Dupilumab in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous UrticariaRecurrent Angioedema
Charite University, Berlin, Germany 72
Testing effectiveness (Phase 2)Study completedNCT02031679
What this trial is testing

Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines

Who this might be right for
Chronic Idiopathic Urticaria
Johns Hopkins University 38
Large-scale testing (Phase 3)Active Not RecruitingNCT06042478
What this trial is testing

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 470
Large-scale testing (Phase 3)Study completedNCT03580356
What this trial is testing

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 1,078
Large-scale testing (Phase 3)Study completedNCT01264939
What this trial is testing

A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists

Who this might be right for
Chronic Idiopathic Urticaria
Genentech, Inc. 336
Testing effectiveness (Phase 2)Study completedNCT01599637
What this trial is testing

Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment

Who this might be right for
Chronic Idiopathic Urticaria
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06445023
What this trial is testing

Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Celldex Therapeutics 963
Testing effectiveness (Phase 2)Study completedNCT03749148
What this trial is testing

Cholinergic Urticaria - Efficacy of Dupilumab

Who this might be right for
Cholinergic Urticaria
Charite University, Berlin, Germany 48
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation